Attorney Aydin Harston participated in a roundtable titled "Trends in Biosimilars" for the October 2018 issue of Financier Worldwide Magazine. As the multi-billion dollar biosimilar market grows, Aydin and others discuss the main trends emerging over the past 12 to 18 months, the impact of recent legislation on the industry, implications of the 2017 Sandoz v. Amgen decision, pricing, and future challenges.
To read the article in its entirety, please access the article on the Financier Worldwide website here.
